Order Total (1 Item Items):
Shipping Destination:
Ernstoff Marc (27 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (27)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (20)
- As New, Fine or Near Fine (3)
- Very Good or Good (2)
- Fair or Poor (2)
- As Described (No further results match this refinement)
Binding
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (8)
- Not Print on Demand (24)
Language (1)
Free Shipping
Seller Location
Seller Rating
-
Hardcover. Condition: Fair. No Jacket. Readable copy. Pages may have considerable notes/highlighting. ~ ThriftBooks: Read More, Spend Less.
-
Hardcover. Condition: Very Good.
-
SITC's Guide to Managing Immunotherapy Toxicity
Language: English
Published by Demos Medical Publishing, 2019
ISBN 10: 0826172148 ISBN 13: 9780826172143
Softcover. Condition: As New. Leichte Kratzer / Abnutzungen / Druckstellen. The Society for Immunotherapy of Cancer's handbook, SITC's Guide to Managing Immunotherapy Toxicity, serves as a practical reference for managing side effects linked to FDA-approved cancer immunotherapy drugs. It is divided into two parts: Part I offers chapter-based overviews of immune checkpoint inhibitors, including anti-CTLA4 and anti-PD1/PD-L1 agents, along with approved combinations. These chapters detail mechanisms of action, indications, and toxicities encountered in early, advanced, and metastatic cancer patients. Part II focuses on common and uncommon toxicities affecting major organ sites. It begins with a general summary of management principles, followed by specific chapters on toxicities such as rash, mucosal irritation, joint and muscle toxicity, diarrhea, pneumonitis, endocrine, neurological, cardiac, renal, hematologic, and ocular toxicities. Each chapter provides guidance on assessing and treating these toxicities, with detailed summary tables for quick reference. Additionally, Part II addresses the management of special patient populations, including those with autoimmune diseases and geriatric patients, as well as treatment for fatigue and the financial impact of care. Written by leading experts in immuno-oncology, this text is an essential resource for clinical oncologists, emergency physicians, and other medical practitioners in both hospital and community settings, especially as immune checkpoint inh.
-
Condition: good. This book is in good condition, with minimal signs of wear and tear.
-
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
-
Condition: Acceptable. SHIPS FAST. RESCUED + REPAIRED. Features a small coffee mishap, plus a reinforced binding, secured cover, and light annotations or highlighting-a durable, fully readable working copy brought back to life at a great value by our Book Sustainability Project. No access codes or CDs.
-
Condition: New.
-
Condition: New.
-
Condition: As New. Unread book in perfect condition.
-
Condition: New. pp. 270.
-
Immune Checkpoint Inhibitors in Cancer
Language: English
Published by Elsevier Science Health Science, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Paperback. Condition: Brand New. 1st edition. 255 pages. 9.00x7.50x0.75 inches. In Stock.
-
Paperback. Condition: Brand New. 1st pap/psc edition. 246 pages. 8.00x5.00x0.65 inches. In Stock.
-
Condition: New. pp. 270.
-
Condition: New. pp. 270.
-
Immune Checkpoint Inhibitors in Cancer
Language: English
Published by Elsevier - Health Sciences Division, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Seller rating 5 out of 5 stars
£ 82.77
£ 17.55 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketPaperback / softback. Condition: New. New copy - Usually dispatched within 4 working days.
-
Urologic Cancer
Language: English
Published by Blackwell Publishing, 1997
ISBN 10: 0865424977 ISBN 13: 9780865424975
Condition: New. pp. xix + 741 Illus.
-
Condition: New. A practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic. Part Two is structured by common and uncommon toxicities that af.
-
Urologic Cancer
Language: English
Published by Blackwell Publishing, 1997
ISBN 10: 0865424977 ISBN 13: 9780865424975
Condition: New. pp. xix + 741 Index.
-
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
-
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
-
Hardcover. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Immune Checkpoint Inhibitors in Cancer
Language: English
Published by Elsevier Health Sciences, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Taschenbuch. Condition: Neu. Immune Checkpoint Inhibitors in Cancer | Fumito Ito (u. a.) | Taschenbuch | Englisch | 2018 | Elsevier Health Sciences | EAN 9780323549486 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.
-
Sitc's Guide to Managing Immunotherapy Toxicity
Language: English
Published by Springer Publishing Company Mär 2019, 2019
ISBN 10: 0826172148 ISBN 13: 9780826172143
Taschenbuch. Condition: Neu. Neuware - A practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic. Part Two is structured by common and uncommon toxicities that affect major organ sites throughout the body.
-
Paperback. Condition: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
-
Condition: new. Questo è un articolo print on demand.
-
Immune Checkpoint Inhibitors in Cancer
Language: English
Published by Elsevier Health Sciences Aug 2018, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today's available information on this timely topic into one convenient resource. 270 pp. Englisch.
-
Immune Checkpoint Inhibitors in Cancer
Language: English
Published by Elsevier Health Sciences, 2018
ISBN 10: 0323549489 ISBN 13: 9780323549486
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Get a quick, expert overview of the latest clinical information and guidelines for cancer checkpoint inhibitors and their implications for specific types of cancers. This practical title by Drs. Fumito Ito and Marc Ernstoff synthesizes the most up-to-date research and clinical guidance available on immune checkpoint inhibitors and presents this information in a compact, easy-to-digest resource. It's an ideal concise reference for trainee and practicing medical oncologists, as well as those in research. Discusses the current understanding of how to best harness the immune system against different types of cancer at various stages. Helps you translate current research and literature into practical information for daily practice. Presents information logically organized by disease site. Covers tumor immunology and biology; toxicities associated with immune checkpoint inhibitors; and future outlooks. Consolidates today's available information on this timely topic into one convenient resource.
